NCT00151047View on ClinicalTrials.gov

Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

January 31, 2005

Study Completion Date

October 31, 2007

Conditions
Prostate Cancer
Interventions
DRUG

Capecitabine

DRUG

Docetaxel

Trial Locations (2)

48109

The University of Michigan Comprehensive Cancer Center, Ann Arbor

Unknown

Wayne State University, Detroit

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00151047 - Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter